Study Details

Back
Study ID 8273-CL-0101
Study Title An open-label study of the oral administration of ASP8273 in patients with non-small cell lung cancer harboring epidermal growth factor receptor (EGFR) mutations
Clinicaltrials.gov Identifier NCT02192697
Compound Name ASP8273 / naquotinib mesilate
Medical Indication or Disease Non-small cell lung cancer
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 23-Jan-2014
Study Completion Date 14-Jun-2017
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS